← FDA DRUG APPROVALS

FDA ANDA · ANDA085432

SODIUM BUTABARBITAL

Sponsor: HIKMA

APPLICATION
ANDA085432
TYPE
ANDA
ORIGINAL APPROVAL
1977-12-20
LATEST ACTION
1991-01-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SODIUM BUTABARBITALDiscontinued
BUTABARBITAL SODIUM 30MG · TABLET · ORAL

Approval history

1991-01-28Manufacturing (CMC) · Supplement 8AP
1989-06-13Labeling · Supplement 7AP
1988-03-18Labeling · Supplement 6AP
1982-11-10Manufacturing (CMC) · Supplement 3AP
1977-12-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →